An in vivo and in vitro H-1-magnetic resonance spectroscopy study of mdx mouse brain: Abnormal development or neural necrosis?

被引:28
作者
Tracey, I [1 ]
Dunn, JF [1 ]
Parkes, HG [1 ]
Radda, GK [1 ]
机构
[1] UNIV OXFORD,DEPT BIOCHEM,MRC,BIOCHEM & CLIN MAGNET RESONANCE UNIT,OXFORD OX1 3QU,ENGLAND
基金
英国惠康基金;
关键词
mdx; H-1-MRS; brain; choline; N-acetyl aspartate; dystrophy; dystrophin-deficiency;
D O I
10.1016/0022-510X(96)00135-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder primarily affecting young boys, often causing mental retardation in addition to the well-known progressive muscular weakness. Normal dystrophin expression is lacking in skeletal muscle and the central nervous system (CNS) of both DMD children and the mdx mouse model. The underlying biochemical lesion causing mental impairment in DMD is unknown. H-1-magnetic resonance spectroscopy (H-1-MRS) detects choline-containing compounds, creatine and N-acetyl aspartate (NAA) in vivo. NAA is commonly used as a chemical marker for neurons, and a decline in NAA is thought to correlate with neuronal loss. Control mice were compared to mdx using a combination of in vivo and in vitro H-1-MRS methods to determine whether neural necrosis or developmental abnormalities occur in dystrophic brain. NAA levels were normal in mdx brain compared to controls suggesting minor, if any, neuronal necrosis in dystrophic brain. In contrast, choline compounds and myo-inositol levels were increased, indicative of gliosis or developmental abnormalities in dystrophic brain.
引用
收藏
页码:13 / 18
页数:6
相关论文
共 52 条
  • [1] PROTON MAGNETIC-RESONANCE SPECTROSCOPY OF HUMAN BRAIN INVIVO IN THE EVALUATION OF MULTIPLE-SCLEROSIS - ASSESSMENT OF THE LOAD OF DISEASE
    ARNOLD, DL
    MATTHEWS, PM
    FRANCIS, G
    ANTEL, J
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1990, 14 (01) : 154 - 159
  • [2] QUANTITATIVE PROTON SPECTROSCOPY OF CANINE BRAIN - IN-VIVO AND IN-VITRO CORRELATIONS
    BARKER, PB
    BREITER, SN
    SOHER, BJ
    CHATHAM, JC
    FORDER, JR
    SAMPHILIPO, MA
    MAGEE, CA
    ANDERSON, JH
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1994, 32 (02) : 157 - 163
  • [3] Blake Derek J., 1994, Trends in Cell Biology, V4, P19, DOI 10.1016/0962-8924(94)90034-5
  • [4] PROTON NMR-SPECTROSCOPY OF CEREBRAL METABOLIC ALTERATIONS IN INFANTILE PEROXISOMAL DISORDERS
    BRUHN, H
    KRUSE, B
    KORENKE, GC
    HANEFELD, F
    HANICKE, W
    MERBOLDT, KD
    FRAHM, J
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1992, 16 (03) : 335 - 344
  • [5] BULLFIELD G, 1984, P NATL ACAD SCI USA, V81, P1189
  • [6] H-1-NMR DETECTION OF CEREBRAL MYOINOSITOL
    CERDAN, S
    PARRILLA, R
    SANTORO, J
    RICO, M
    [J]. FEBS LETTERS, 1985, 187 (01) : 167 - 172
  • [7] EXPRESSION OF THE MURINE DUCHENNE MUSCULAR-DYSTROPHY GENE IN MUSCLE AND BRAIN
    CHAMBERLAIN, JS
    PEARLMAN, JA
    MUZNY, DM
    GIBBS, RA
    RANIER, JE
    REEVES, AA
    CASKEY, CT
    [J]. SCIENCE, 1988, 239 (4846) : 1416 - 1418
  • [8] CHARLES HC, 1992, P SOC MAGNETIC RESON, P757
  • [9] DYSTROPHIN GENE TRANSCRIBED FROM DIFFERENT PROMOTERS IN NEURONAL AND GLIAL-CELLS
    CHELLY, J
    HAMARD, G
    KOULAKOFF, A
    KAPLAN, JC
    KAHN, A
    BERWALDNETTER, Y
    [J]. NATURE, 1990, 344 (6261) : 64 - 65
  • [10] A DYSTROPHIN-IMMUNOREACTIVE PROTEIN IN MAMMALIAN BRAIN
    CLERK, A
    MUNTONI, F
    STRONG, PN
    [J]. JOURNAL OF NEUROCHEMISTRY, 1993, 60 (02) : 435 - 441